Asian shares slip as hope fades on drug to treat Covid-19
Shares in China fall as antiviral drug remdesivir fails to help severely ill patients in clinical trial
24 April 2020 - 07:55
Tokyo/Washington — Asian shares and US stock futures fell on Friday, spurred by doubts about progress in the development of drugs to treat Covid-19 and new evidence of US economic damage caused by the coronavirus pandemic.
MSCI’s broadest index of Asia-Pacific shares outside Japan was down 0.4%. US stock futures, the S&P 500 e-minis, were down 0.72%...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.